Product Name | Lenvatinib |
CAS | 417716-92-8 |
MF | C21H19ClN4O4 |
EINECS | 1592732-453-0 |
MOQ | 1 kg, please consult for details |
Sample And Customize | Support |
Delivery Time | 7-15 days |
Shipping Method | sea freight,land transport,air transport,express delivery |
Package | standard packaging |
Payment Method | ALL |
Place of Origin | Shandong China |
Brand | Fousi |
Production Capacity | 1000 tons/year |
Quality | Top Quality |
Lenvatinib is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well.Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).
It is currently used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of renal cell cancer and other tumours. Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers.
Packing: 25kg/Drum
Delivery: by sea, air and courier
Low temperature ventilation and drying in warehouse